EGFR and cancer: The KEGG analysis identified that this signature involved in the high-risk group was significantly enriched in WNT signaling pathway, MAPK signaling pathway, ERBB signaling pathway, bladder cancer, and pathways in cancer and focal adhesion, which were similar to the enrichment analysis of 41 HRGs, suggesting that this signature was closely associated to hypoxia.